We are live on ! Find out more
BCTXW

BriaCell Therapeutics Corp Warrant

Delisted

BCTXW was delisted on the 26th of February, 2026.

8 hedge funds and large institutions have $4.31M invested in BriaCell Therapeutics Corp Warrant in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more capital invested

Capital invested by funds: $1.58M → $4.31M (+$2.73M)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

20% less funds holding

Funds holding: 108 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

102% less ownership

Funds ownership: 114.02%12.01% (-102%)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$1.78M
M
2
Murchinson
Ontario, Canada
$1.21M +$379K +154,437 +154%
KJHP
3
K.J. Harrison & Partners
Ontario, Canada
$556K +$286K +116,446 New
RAM
4
Redmond Asset Management
Virginia
$363K
ZCA
5
Zeke Capital Advisors
Pennsylvania
$214K
WAM
6
Warberg Asset Management
Illinois
$130K -$12.3K -5,000 -16%
Morgan Stanley
7
Morgan Stanley
New York
$51K
UBS Group
8
UBS Group
Switzerland
$10K +$5.11K +2,082 New
ACM
9
Altium Capital Management
New York
-$377K -209,540 Closed
VF
10
Virtu Financial
New York
-$19K -10,445 Closed
Jane Street
11
Jane Street
New York
-$18K -10,181 Closed
IP
12
Intellectus Partners
California
-$18K -10,000 Closed

BCTXW Hedge Fund Activity: Q3 2021 in Review

8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q3 2021, worth a combined $4.31M — up 173% from $1.58M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BCTXW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Murchinson, adding an estimated $379K. The largest seller was Altium Capital Management, exiting entirely with an estimated $377K sold.

  • 8 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q3 2021, down from 10 in Q2 2021.
  • Funds reported $4.31M of BriaCell Therapeutics Corp Warrant stock for Q3 2021, up 173% quarter-over-quarter.
  • 2 funds opened new BriaCell Therapeutics Corp Warrant positions in Q3 2021 and 4 closed out, a net change of -2 holders.
  • The largest BriaCell Therapeutics Corp Warrant buyer in Q3 2021 was Murchinson, an estimated $379K added.
  • The largest BriaCell Therapeutics Corp Warrant seller in Q3 2021 was Altium Capital Management, an estimated $377K sold.

Based on aggregated 13F filings for Q3 2021.